The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump ...

Pfizer (PFE) stock in focus as company faces lawsuits over its alleged failure to warn about brain tumor risks linked to Depo ...

A new study reveals that Pfizer’s COVID-19 vaccine may cause subtle but measurable changes in the eyes — specifically in the ...

A new study has linked a type of injectable birth control with meningioma. The manufacturer says the claims are “without ...

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

Dozens of alumni of a group the State Department has linked to espionage have secured jobs in sensitive industries.

A new study allegedly discovered that women using a specific form of birth control had a "significantly higher risk" of ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) granting Pfizer exclusive rights for the development, manufacturing and ...

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

SmallCap stocks can often be overlooked by institutional investors, yet they offer outsized return potential for those ...

In the same week that crypto exchange VALR launches a USD private credit token targeting 8% to 10% growth a year.

Roche reported better than expected first-half operating profit, driven by strong sales of breast cancer and asthma ...